Fluorescein-mediated sonodynamic therapy in a rat glioma model

Francesco Prada1,2,3, Natasha Sheybani4, Andrea Franzini5,6

  • 1Department of Neurological Surgery, University of Virginia Health Science Center, Charlottesville, VA, USA. francesco.prada@istituto-besta.it.

Abstract

Insights

Sonodynamic therapy (SDT) using fluorescein (FL) and focused ultrasound (FUS) effectively inhibited ectopic glioma growth in rats. This approach shows promise for treating malignant gliomas by targeting tumor-specific accumulation of FL.

Area of Science:

  • Oncology
  • Biophysics
  • Medical Imaging

Background:

  • Malignant gliomas have poor prognoses, necessitating novel therapeutic strategies.
  • Sonodynamic therapy (SDT) combines ultrasound and sonosensitizers for localized cancer treatment.
  • Fluorescein (FL) is explored as a sonosensitizer for SDT.

Purpose of the Study:

  • To evaluate the efficacy of SDT with fluorescein (FL) and low-intensity focused ultrasound (FUS) in inhibiting ectopic glioma growth in rats.
  • To assess tumor-specific FL accumulation and its impact on tumor growth.

Main Methods:

  • In vivo cytotoxicity of FL-SDT was assessed in C6 rat glioma cells implanted subcutaneously.
  • Tumor-specific FL extravasation and accumulation were visualized using IVIS imaging.
  • Tumor growth inhibition and histological changes were analyzed post-FL-SDT treatment.

Main Results:

  • IVIS imaging confirmed significant FL accumulation within tumors.
  • FL-SDT significantly inhibited ectopic C6 glioma outgrowth under all tested FUS conditions.
  • Apoptosis markers (TUNEL, active caspase-3) did not show conclusive trends.

Conclusions:

  • SDT with FL and low-intensity FUS demonstrates efficacy in inhibiting ectopic malignant glioma growth in rats.
  • Selective FL accumulation suggests tumor-specificity, potentially related to blood-brain barrier disruption.
  • Further research is warranted to explore SDT's potential in intracranial models and human gliomas.

Related Concept Videos